Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome: A case report.

about

Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome: A case report.

Item

http://www.wikidata.org/entity/Q47547095

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Efficacy of eculizumab in an a ...... remic syndrome: A case report.

@en

Efficacy of eculizumab in an a ...... remic syndrome: A case report.

@nl

type

Item

label

Efficacy of eculizumab in an a ...... remic syndrome: A case report.

@en

Efficacy of eculizumab in an a ...... remic syndrome: A case report.

@nl

prefLabel

Efficacy of eculizumab in an a ...... remic syndrome: A case report.

@en

Efficacy of eculizumab in an a ...... remic syndrome: A case report.

@nl

P1476

Efficacy of eculizumab in an a ...... remic syndrome: A case report.

@en

P2093

Alexandre Lautrette

http://www.w3.org/2001/XMLSchema#string

Anne Elisabeth Heng

http://www.w3.org/2001/XMLSchema#string

Cyril Garrouste

http://www.w3.org/2001/XMLSchema#string

Marine Freist

http://www.w3.org/2001/XMLSchema#string

Nora Szlavik

http://www.w3.org/2001/XMLSchema#string

Paul Coppo

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity.

Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient.

Human immunodeficiency virus associated thrombotic thrombocytopenic purpura--favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy.

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Managing atypical hemolytic uremic syndrome: chapter 2.

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

P304

e9358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000009358

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29390523

http://www.w3.org/2001/XMLSchema#string

P932

5758225

http://www.w3.org/2001/XMLSchema#string